Eosinophilic oesophagitis trials in Germany

2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of ANB033

  Where

  Erlangen, Hamburg, Leipzig, Mainz, Munich

  Age

  18 years and over

  People

  48 worldwide

  Run by

  First Tracks Biotherapeutics Inc.

  See details and how to join2024-520409-38-00
• No phaseTaking people
  A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany

  Where

  Aschaffenburg, Augsburg, Berlin, Bochum, Burbach, Dachau, Erlangen, Giessen, Guelders, Leipzig, Magdeburg, Münster, Osnabrück, Wetzlar, Weyhe-Kirchweyhe

  Age

  12 years and over

  People

  150

  Run by

  Sanofi

  See details and how to joinNCT06695897